

Tänker fortsätta såhär fram tills dagen-d.
) dra 200-400mg på 5-htp på morgonen sägs kunna boosta effekten men samtidigt säger mycket emot och att det kan vara farligt pga serotogent syndrom, men säg att jag tar 400mg 5-htp typ 8:00 på morgonen och sen trycker en till 200-220mg bomb kristaller på kvällen, vad tror ni om faran? Kan tillägga att jag även kommer suga upp en hel del tjack i snoken under festivalen.
Gäller ju att knarka ansvarsfullt
!

!
?Long-term effects
MDMA use has been shown to produce brain lesions, a form of brain damage, in the serotonergic neural pathways of humans and other animals.[2][4] In addition, long-term exposure to MDMA in humans has been shown to produce marked neurotoxicity in serotonergic axon terminals.[18][22][30] Neurotoxic damage to axon terminals has been shown to persist for more than two years.[30] Brain temperature during MDMA use is positively correlated with MDMA-induced neurotoxicity in animals.[18] Adverse neuroplastic changes to brain microvasculature and white matter also seem to occur in humans using low doses of MDMA.[18] Reduced gray matter density in certain brain structures has also been noted in human MDMA users.[18] In addition, MDMA has immunosuppressive effects in the peripheral nervous system, but pro-inflammatory effects in the central nervous system.[31] Babies of mothers who used MDMA during pregnancy exhibit impaired motor function at 4 months of age, which may reflect either a delay in development or a persistent neurological deficit.[16][32]
MDMA also produces persistent cognitive impairments in human users.[1][15][16] Impairments in multiple aspects of cognition, including memory, visual processing, and sleep have been noted in humans;[15][16] the magnitude of these impairments is correlated with lifetime ecstasy or MDMA usage.[1][15][16] Memory is significantly impacted by ecstasy use, which is associated with marked impairments in all forms of memory (e.g., long-term, short-term, working).[15][16]
Long-term effects (MDMA Wikipedia)
Ecstasy is a widely used recreational drug that usually consists primarily of 3,4-methylenedioxymethamphetamine (MDMA). Most ecstasy users consume other substances as well, which complicates the interpretation of research in this field. The positively rated effects of MDMA consumption include euphoria, arousal, enhanced mood, increased sociability, and heightened perceptions; some common adverse reactions are nausea, headache, tachycardia, bruxism, and trismus. Lowering of mood is an aftereffect that is sometimes reported from 2 to 5 days after a session of ecstasy use. The acute effects of MDMA in ecstasy users have been attributed primarily to increased release and inhibited reuptake of serotonin (5-HT) and norepinephrine, along with possible release of the neuropeptide oxytocin. Repeated or high-dose MDMA/ecstasy use has been associated with tolerance, depressive symptomatology, and persisting cognitive deficits, particularly in memory tests. Animal studies have demonstrated that high doses of MDMA can lead to long-term decreases in forebrain 5-HT concentrations, tryptophan hydroxylase activity, serotonin transporter (SERT) expression, and visualization of axons immunoreactive for 5-HT or SERT. These neurotoxic effects may reflect either a drug-induced degeneration of serotonergic fibers or a long-lasting downregulation in 5-HT and SERT biosynthesis. Possible neurotoxicity in heavy ecstasy users has been revealed by neuroimaging studies showing reduced SERT binding and increased 5-HT2A receptor binding in several cortical and/or subcortical areas. MDMA overdose or use with certain other drugs can also cause severe morbidity and even death. Repeated use of MDMA may lead to dose escalation and the development of dependence, although such dependence is usually not as profound as is seen with many other drugs of abuse. MDMA/ecstasy-dependent patients are treated with standard addiction programs, since there are no specific programs for this substance and no proven medications. Finally, even though MDMA is listed as a Schedule I compound by the Drug Enforcement Agency, MDMA-assisted psychotherapy for patients with chronic, treatment-resistant posttraumatic stress disorder is currently under investigation. Initial results show efficacy for this treatment approach, although considerably more research must be performed to confirm such efficacy and to ensure that the benefits of MDMA-assisted therapy outweigh the risks to the patients.
3,4-methylenedioxymethamphetamine (MDMA): current perspectives
Den centralnervösa effekten orsakas främst av en serotoninfrisättning i hjärnans centrala delar främst limbiska systemet och hippocampus, men efter långvarigt bruk uttöms serotonerga depåer och patienterna utvecklar negativa mentala symtom, depressioner och ibland psykoser.
Exempel på negativa effekter:
Hyperaktivitet och hypomani (akatisier)Droganvändaren blir med tiden efter upprepat intag utmattad, irriterad och deprimerad. Patientens nedstämdhet kan vara svårbehandlad och långdragen. Experimentella djurdata tyder på att skador på dopaminbanor och framför allt serotoninbanor är morfologiska och delvis irreversibla. Även generella kramper förekommer.
Tankeflykt, instabilt temperament
Oro, rastlöshet, ångest, irritabilitet
Försämrad självkontroll, distanslöshet, instabilt beteende
Gränslös sexuell aktivitet
Ökad aptit, hetsätande (men även aptitlöshet och anorexi)
Huvudvärk
Psykosliknande reaktioner, hallucinationer
Symtom som kan uppträda efter några månaders missbruk är:
Trötthet, orkeslöshet, nedstämdhetBehandling med antidepressiva läkemedel (SSRI-preparat) mot nedstämdhet fungerar sämre än normalt efter missbruk av ecstasy. Användaren får sämre effekt av förnyat intag av ecstasy. Vid långvarigt missbruk utvecklar många patienter en kognitiv dysfunktion - minne och inlärningsförmåga försämras väsentligt.
Sömnsvårigheter
Stereotypt beteende, tics
Depression
Paranoia
Ångest
Mutism
Katatonier
Intoxikation och missbruk - Ecstasy
Du måste vara medlem för att kunna kommentera